Roche has more at risk than Genentech
January 30, 2009 at 12:42 PM EST
A MarketWatch First Take commentary published Jan. 30 on Roche's new offer for Genentech erroneously reported the company's per-share offer. The correct figure is $86.50 a share. See full story.
